Are Notified Bodies AI-Ready? BSI Teams Up With Expert Firm On Conformity Assessments
Executive Summary
BSI Group has partnered with Japan’s Citadel AI to ensure that where necessary, medical devices based on artificial intelligence (AI) are assessed rigorously for regulatory compliance. The notified body explains why this partnership is necessary for complex AI products.
You may also be interested in...
EU AI Act Legal Deep-Dive Part 2: Balancing Medtech Innovation With Safety
The EU AI Act could introduce rigorous regulatory requirements for AI-based medical devices in addition to those contained in the MDR/IVDR. Lawyers from Cooley LLP tell Medtech Insight how changes to the commission’s proposal could improve its impact on medtech while keeping patients safe.
EU Orphan Drug Law Reform Will See Innovation Drop By 12%, Industry Warns
The European Commission’s proposals to overhaul the EU pharma legislation, which will see some orphan drug incentives cut, would cause a “significant dip in innovation,” according to number crunching from pharma industry association EFPIA.
Tackling AMR: OECD Says Greater Investment Needed In Later-Stage Drug R&D
Governments should increase financial resources for novel antimicrobial drug candidates in the later stages of development and tackle shortages of existing, underused antibiotics to combat antimicrobial resistance, says a new report from the OECD.